REICH, K.; LEBWOHL, M.; PAUL, C.; ROPKE, M.; ROSEN, M.; HANSEN, K. Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S1, 2018. DOI: 10.25251/skin.2.supp.1. Disponível em: https://jofskin.org/index.php/skin/article/view/254. Acesso em: 3 jul. 2024.